Evidence map›Paper›PMID 30271135›Full record

ArticleInternational journal of chronic obstructive pulmonary disease

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function.

Kylie Br Belchamber, Catherine Mr Thomas, Amy E Dunne, Peter J Barnes, Louise E Donnelly

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Macrophages and the microbiome in chronic obstructive pulmonary disease.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Leukocyte Function in COPD: Clinical Relevance and Potential for Drug Therapy.International journal of chronic obstructive pulmonary disease · 2021
    Review
  10. Replication of Crohn's Disease MucosalPathogens (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Kylie Br BelchamberAirway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK, l.donnelly@imperial.ac.uk.
Catherine Mr ThomasAirway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK, l.donnelly@imperial.ac.uk.
Amy E DunneAirway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK, l.donnelly@imperial.ac.uk.
Peter J BarnesAirway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK, l.donnelly@imperial.ac.uk.
Louise E DonnellyAirway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK, l.donnelly@imperial.ac.uk.
Lung Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInhaled corticosteroid use is associated with increased rates of pneumonia in COPD patients. The underlying mechanism is unknown, although recent data suggest that pneumonia is more frequent in patients treated with fluticasone propionate (FP) than budesonide. Macrophages and neutrophils from COPD patients are deficient in clearing bacteria, and this might explain increased bacterial colonization in COPD. Inhaled corticosteroid may further suppress this response; therefore, we examined the effect of FP and budesonide on phagocytosis of common respiratory pathogens by monocyte-derived macrophages (MDMs) and neutrophils.

methodsMDMs from COPD patients (n=20-24) were preincubated with FP or budesonide for 1 or 18 hours, after which phagocytosis of fluorescently labeled inert beads or heat-killed

resultsAfter 1 hour's preincubation, neither corticosteroid altered MDM phagocytosis of beads or

conclusionThese data suggest that dissolved FP and budesonide do not have an overall effect on MDM or neutrophil phagocytosis of bacteria.

Indexed as

AgedBudesonideCells, CulturedCohort StudiesEnzyme-Linked Immunosorbent AssayFemaleFluticasoneHaemophilus influenzaeHumansMacrophagesMaleNeutrophilsPhagocytosisPulmonary Disease, Chronic ObstructiveSensitivity and SpecificityStreptococcus pneumoniaeBudesonideFluticasonebudesonideCOPDfluticasone propionatemacrophageneutrophil

Identifiers

PMID30271135
PMCPMC6147211
OpenAlexW2890066218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.